# ASENAPINE MALEATE
> **ANDA206107** · Abbreviated New Drug Application (Generic) · Sponsor: SIGMAPHARM LABS LLC · Approved 2020-12-10
## Drug
- **FDA Application Number:** ANDA206107
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ASENAPINE MALEATE
- **Generic name:** ASENAPINE
- **Active ingredients:** ASENAPINE MALEATE
- **Dosage form:** TABLET
- **Route:** SUBLINGUAL
- **Marketing status:** Prescription
- **Sponsor:** SIGMAPHARM LABS LLC
- **Manufacturer:** Sigmapharm Laboratories, LLC
- **First approval:** 2020-12-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206107)
---
*MORVS · CC0 1.0*